Skip to content
Review Open access

RNF213 in Panvascular Disease: A Molecular Hub Linking Genetic Susceptibility to Systemic Vasculopathy

Aug 2026 · Biomedicines · Vol 14, pp. 1748 · 0 citations · 312 references
Medicine

TL;DR

This review synthesizes current evidence elucidating RNF213′s multifaceted roles in vascular homeostasis, spanning its functions as an E3 ubiquitin ligase, mechanosensor, and immune modulator and outlines unresolved questions regarding context-dependent effects of RNF213 variants and organ-specific regulatory mechanisms.

Abstract

Panvascular diseases, characterized by systemic vascular dysfunction across multiple organ systems, represent a complex interplay of genetic susceptibility and environmental triggers. Ring Finger Protein 213 (RNF213), initially identified as the principal susceptibility gene for moyamoya disease (MMD), has emerged as a central regulator of panvascular pathophysiology. This review synthesizes current evidence elucidating RNF213′s multifaceted roles in vascular homeostasis, spanning its functions as an E3 ubiquitin ligase, mechanosensor, and immune modulator. The “second-hit” hypothesis posits that RNF213 mutations establish a genetic predisposition, while secondary insults—such as infection, hypoxia, or hemodynamic stress—precipitate pathological manifestations. Mechanistically, RNF213 orchestrates critical processes including endothelial integrity, angiogenesis, and inflammatory responses through pathways such as HIF-1α/VEGF, NF-κB, and Wnt signaling. Its dysfunction disrupts vascular remodeling, promotes aberrant smooth muscle proliferation, and exacerbates hypoxia-inflammation cycles, contributing to diverse pathologies ranging from intracranial aneurysms and arterial dissections to pulmonary hypertension and coronary artery disease. Emerging insights into RNF213′s interactions with gut microbiota, lipid metabolism, and epigenetic regulators further underscore its systemic influence. Despite advancements, unresolved questions persist regarding the context-dependent duality of RNF213 variants and organ-specific regulatory mechanisms. This review highlights the imperative for integrated approaches combining genetic, molecular, and environmental perspectives to unravel RNF213′s panvascular roles. We also outline unresolved questions regarding context-dependent effects of RNF213 variants and organ-specific regulatory mechanisms, and discuss potential avenues for future research integrating genetic, molecular, and environmental perspectives to advance understanding of RNF213′s panvascular roles.

Read PDF

Similar papers

Review Open access Jan 2026

TREM2: A Potential Target for the Targeted Therapy of Metabolic Diseases

This review systematically summarize recent advances in understanding the roles of TREM2 in major metabolic diseases, including atherosclerosis, diabetes mellitus and its complications, obesity, and non‐alcoholic steatohepatitis, while highlighting its functional heterogeneity across different diseases contexts.

Ya-Ling Li, Sheng-Quan Liu, C. Chu et al. · 0 citations
Review Open access Sep 2026

S100A8/A9 in Kidney Diseases: Mechanisms, Spatiotemporal Regulation, Biomarker Potential, and Therapeutic Implications

A spatiotemporal framework is proposed that extends beyond previous disease- or pathway-centered perspectives by integrating the timing and cellular context of S100A8/A9 signaling to establish stage-specific biomarker and therapeutic strategies targeting S100A8/A9 in precision nephrology.

Meng-Ge Zhu, Meng-Dan Lu, Jia-Wei Cao et al. · 0 citations
Review Open access Aug 2026

JCAD/KIAA1462: biology, pathophysiology, and translational perspectives in vascular disease.

Junctional cadherin 5-associated protein (JCAD/KIAA1462) is an endothelial junctional protein encoded by a locus robustly associated with coronary artery disease and myocardial infarction in genome-wide association studies. Initially identified as a structural component of endothelial cell-cell junctions, JCAD has sinc...

M. Moriero, S. Kraler, A. Tirandi et al. · 0 citations
Review Open access Sep 2026

GNA15 as a regulator of tumor–immune crosstalk: oncogenic signaling, microenvironmental remodeling, and implications for targeted immunotherapy

GNA15 is a Gαq-family G protein whose physiological expression is largely restricted to hematopoietic cells. Nevertheless, aberrant upregulation has been reported in six histologically distinct malignancies, with elevated expression consistently associated with adverse clinical outcomes. Unlike the ubiquitously express...

Aarka Undar, Shweta Sunil Nambiar, Mukil Srivasan et al. · 0 citations
Review Open access Aug 2026

Research progress on BTG2 in non-tumor diseases (Review)

This review systematically synthesizes advances in the pivotal, context-dependent roles of BTG2 in non-tumor pathologies, including fibrotic, neurological, cardiovascular, inflammatory, metabolic and other systemic diseases.

Shu-Ling Li, Xiao-Mei Liu, Zheng Zhang et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.